From Elsevier Business Intelligence
Including company and deal data plus articles from publications like IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

Merck & Co. Inc.

www.merck.com

Most Recent Related Deals

Alectos grants Merck rights to Alzheimer's candidates, 8/2010
Merck grants LabCorp nonexclusive hepatitis C rights, 7/2010
Merck buys dengue fever vaccine bus. from Hawaii Biotech, 7/2010
Sinopharm, Merck sign letter of intent for vaccine sales, 7/2010
Glenmark and Merck settle ezetimibe litigation, 5/2010
Merck pairs with ElexoPharm for cardiovascular disease, 5/2010
Merck enhances adult vaccine portfolio through UMass deal, 4/2010
Merck to co-promote Daxas with Nycomed in Europe and Canada, 4/2010
Merck gets access to Roche's AmpliChip p53 test, 2/2010
Envoy assists Merck with new obesity and diabetes treatments, 1/2010

Most Recent Related Articles

Click an article to see a free preview (15 of 879).

Deals Update, The Pink Sheet DAILY 8/2010
Calithera Biosciences: UCSF Spin-out Takes $40 Million First Round, In Vivo 7/2010
Personalizing Patient Care:Sanofi Recasts Its Diabetes Efforts, Start-Up 7/2010
Welcome To Europe, Medtech Insight 6/2010
The Challenge Of Pricing Amgen's Newly Approved Prolia, Start-Up 6/2010
Marcadia Biotech Inc., In Vivo 6/2010
Altering The Insulin Resistance System, In Vivo 6/2010
Genentech's New Deal Maker, In Vivo 6/2010
AZ and Merck: Moving Forward Cautiously , Start-Up 5/2010
TYRX: Is This the Model for Drug/Device Convergence?, Start-Up 5/2010
Novartis Follows Its Own Business Development Model into Molecular Diagnostics , Start-Up 5/2010
The Rise Of Japanese Pharma Dealmakers, Start-Up 5/2010
Medtech Venture Investing 2010: Do the Right Thing , In Vivo 5/2010
Peptide Therapeutics' Rising Tide, In Vivo 5/2010
Start-Up Quarterly Statistics, Q1 2010, In Vivo 5/2010

See all 879 articles about this company

Copyright © 2009 Elsevier Inc. All rights reserved. Elsevier Business Intelligence, www.ElsevierBI.com.
Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com.